Top

Published in:

01-06-2010 | Lecture: The School Association for Headache

Remarks on an educational training course on headache

Authors: G. Casucci, V. Villani, F. Frediani

Published in: Neurological Sciences | Special Issue 1/2010

Abstract

In the last years several studies have been performed on migraine; however, only few topics have changed the clinical practice. Among these, there are physiopathological insights (e.g., allodynia and gastric stasis) or therapeutical evidences (e.g., topiramate) that become very important in the management of migraine and could clarify the different response to the therapies. The aim of a training school on headache should be to link research to practice without transferring contradictory data. To teach is not only to support notions with simple data: we think that knowledge has to be used according to the condition of the patient and the situation in which the migraineurs live.

Burstein R, Yarnitsky D, Goor-Aryeh I et al (2000) An association between migraine and cutaneous allodynia. Ann Neurol 47:614–624PubMedCrossRef

Winkelstein BA (2004) Mechanism of central sensitization, neuroimmunology and injury biomechanics in persistent pain. Implications for musculoskeletal disorders. J Electromyogr Kinesiol 14:87–93PubMedCrossRef

Burstein R, Cutrer MF, Yarnitsky D (2000) The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 123:1703–1709PubMedCrossRef

Lipton RB, Bigal ME, Ashina S et al (2008) Cutaneous allodynia in the migraine population. Ann Neurol 63:148–158PubMedCrossRef

Bigal ME, Ashina S, Burstein R et al (2008) Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology 70:1525–1533PubMedCrossRef

Cooke L, Eliasziw M, Becker WJ (2007) Cutaneous allodynia in transformed migraine patients. Headache 47:531–539PubMed

LoPinto C, Young WB, Ashkenazi A (2006) Comparison of dynamic (brush) and static (pressure) mechanical allodynia in migraine. Cephalalgia 26:852–856PubMedCrossRef

Tietjen GE, Brandes JL, Peterlin BL et al (2009) Allodynia in migraine: association with comorbid pain conditions. Headache 49:1333–1344PubMedCrossRef

Burstein R, Jakubowski M (2004) Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann Neurol 55:27–36PubMedCrossRef

10.

Burstein R, Collins B, Jakubowski M (2004) Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 55:19–26PubMedCrossRef

11.

Silberstein SD, Young WB, Hopkins MM et al (2007) Dihydroergotamine for early and late treatment of migraine with cutaneous allodynia: an open-label pilot trial. Headache 47:878–885PubMedCrossRef

12.

Jakubowski M, Levy D, Goor-Aryeh I et al (2005) Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors. Headache 45:850–861PubMedCrossRef

13.

Volans GN (1975) The effect of metoclopramide on the absorption of effervescent aspirin in migraine. Br J Clin Pharmacol 2:57–63PubMed

14.

Tokola RA (1988) The effect of metoclopramide and prochlorperazine on the absorption of effervescent paracetamol in migraine. Cephalalgia 8:139–147PubMedCrossRef

15.

Aurora S, Kori S, Barrodale P, Nelsen A et al (2007) Gastric stasis occurs in spontaneous, visually induced, and interictal migraine. Headache 47:1443–1446 (Epub Sept 12 2007)PubMedCrossRef

16.

Jakubowski M, Levy D, Kainz V et al (2007) Sensitization of central trigeminovascular neurons: blockade by intravenous naproxen infusion. Neuroscience 148:573–583 (Epub 25 Jul 2007)PubMedCrossRef

17.

Aurora SK, Kori SH, Barrodale P et al (2006) Gastric stasis in migraine: more than just a paroxysmal abnormality during a migraine attack. Headache 46:57–63PubMedCrossRef

18.

Silberstein SD, Neto W, Schmitt J et al (2004) Topiramate in migraine prevention: results of a large controlled trial. JAMA 291:965–973CrossRef

19.

Bussone G, Diener HC, Pfeil J et al (2005) Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials. Int J Clin Pract 59:961–968PubMedCrossRef

20.

D’Amico D, Tepper SJ (2008) Prophylaxis of migraine: general principles and patient acceptance. Neuropsychiatr Dis Treat 4:1–13

21.

Diener HC, Agosti R, Allais G, For the TOPMAT-MIG-303 Investigators Group et al (2007) Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo controlled trial. Lancet Neurol 6:1054–1062PubMedCrossRef

22.

Rapaport A, Mauskop A, Diener HC et al (2006) Long-term migraine prevention with topiramate: open label extension of pivotal trials. Headache 46:1151–1160CrossRef

23.

Naegel S, Obermann M (2010) Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference. Neuropsychiatr Dis Treat 6:17–28PubMed

Title: Remarks on an educational training course on headache
Authors: G. Casucci
V. Villani
F. Frediani
Publication date: 01-06-2010
Publisher: Springer Milan
Published in: Neurological Sciences / Issue Special Issue 1/2010
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-010-0301-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Remarks on an educational training course on headache

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 1/2010

Clinical considerations on chronic migraine, pharmacoresistance and refractoriness

Hypertension as a risk factor for migraine chronification

Neuromodulation for refractory headaches

Fabry disease in patients with migraine with aura

Dissection of the epiaortic and intracranial arteries

Proposal for a new classification of chronic headache